Revenue from Contract with Customer, Excluding Assessed Tax of IMMUCELL CORP /DE/ from 31 Mar 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
IMMUCELL CORP /DE/ quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Mar 2017 to 30 Sep 2025.
  • IMMUCELL CORP /DE/ Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Sep 2025 was $5,506,122, a 8.4% decline year-over-year.
  • IMMUCELL CORP /DE/ annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $26,493,169, a 52% increase from 2023.
  • IMMUCELL CORP /DE/ annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $17,471,669, a 5.9% decline from 2022.
  • IMMUCELL CORP /DE/ annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $18,567,962, a 3.5% decline from 2021.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)

IMMUCELL CORP /DE/ Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $5,506,122 -$505,451 -8.4% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q3 2024 $6,011,573 +$615,073 +11% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2023 $5,396,500 +$600,475 +13% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $4,796,025 -$354,148 -6.9% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q3 2021 $5,150,173 01 Jul 2021 30 Sep 2021 10-Q 21 Nov 2022 2022 Q3
Q2 2018 $3,014,546 +$1,264,941 +72% 01 Apr 2018 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 $2,881,185 -$662,745 -19% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q2 2017 $1,749,605 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018 2018 Q2
Q1 2017 $3,543,930 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1

IMMUCELL CORP /DE/ Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $26,493,169 +$9,021,500 +52% 01 Jan 2024 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
2023 $17,471,669 -$1,096,293 -5.9% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2024 2023 FY
2022 $18,567,962 -$675,007 -3.5% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $19,242,969 +$3,900,765 +25% 01 Jan 2021 31 Dec 2021 10-Q 13 Nov 2023 2023 Q3
2020 $15,342,204 01 Jan 2020 31 Dec 2020 10-Q 21 Nov 2022 2022 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.